Riverbridge Partners LLC Decreased Stake in Proto Labs INC (PRLB) as Shares Rose

Proto Labs, Inc. (NYSE:PRLB) Corporate LogoDuring Q2 2018 the big money sentiment increased to 1.31. That’s change of 0.24, from 2018Q1’s 1.07. 23 investors sold all, 58 reduced holdings as PRLB ratio increased. 79 grew stakes while 27 funds amassed stakes. Funds hold 25.28 million shares thus 3.36% more from 2018Q1’s 24.46 million shares. Amundi Pioneer Asset Management Incorporated owns 0.01% invested in Proto Labs, Inc. (NYSE:PRLB) for 48,820 shs. Suffolk Cap Mgmt Ltd Co reported 7,141 shs stake. Ohio-based Meeder Asset Mgmt Incorporated has invested 0% in Proto Labs, Inc. (NYSE:PRLB). Matarin Cap Mgmt Llc invested 0% of its capital in Proto Labs, Inc. (NYSE:PRLB). Aperio Grp Incorporated Limited invested in 0.01% or 9,377 shs. Wolverine Asset Mgmt Lc owns 0.02% invested in Proto Labs, Inc. (NYSE:PRLB) for 15,256 shs. The Washington-based Parametric Associates Llc has invested 0.01% in Proto Labs, Inc. (NYSE:PRLB). Connecticut-based Bradley Foster And Sargent Incorporated Ct has invested 0.03% in Proto Labs, Inc. (NYSE:PRLB). First Republic Investment Mgmt Inc has invested 0% in Proto Labs, Inc. (NYSE:PRLB). Conestoga Capital Ltd Limited Liability Company has 2.32% invested in Proto Labs, Inc. (NYSE:PRLB) for 605,631 shs. Principal Finance Gp reported 207,169 shs. 11,708 were reported by Fmr Limited Company. Carroll Fincl Assoc reported 0% of its capital in Proto Labs, Inc. (NYSE:PRLB). Manufacturers Life Insurance Co The reported 0% of its capital in Proto Labs, Inc. (NYSE:PRLB). Bell Bancorp owns 7,984 shs.

PRLB registered $4.60 million net activity with 0 buys and 9 sales since June 12, 2018. 3,474 shs were sold by Baker Arthur R. III, worth $537,815 on Tuesday, September 4. On Friday, June 15 Bodor Robert also sold $404,904 worth of Proto Labs, Inc. (NYSE:PRLB). On Monday, September 24 $1.27 million worth of stock was sold by WAY JOHN.

In 2018Q2 SEC form is reported Riverbridge Partners Llc’s stake in Proto Labs Inc. (PRLB) which was decreased by 2.89%. 51,515 shares were sold by Riverbridge Partners Llc as the company’s stock rose 21.19% with the market. The capital goods company announced $206.15 million value for the 2018Q2. Now the hedge fund is holding 1.73M shares, compared to the 1.78 million from the previous quarter. $3.48 billion is Proto Labs Inc.’s market cap. The stock increased 1.54% or $1.95 during the last trading session, touching $128.69.Proto Labs, Inc. has volume of 153,589 shares. Since December 3, 2017 PRLB has risen 113.13% and is uptrending. The stock outperformed the S&P500 by 97.51%.

About $5.72 billion and $5.55 billion US Long portfolio Riverbridge Partners Llc operates. According to a filing the fund increased its stake in Exponent Inc. (NASDAQ:EXPO) by 417,399 shares to 848,810 shares, valued at $41.00 million in 2018Q2. For a total of 3.54 million shares it increased its holding in Evolent Health Inc. Class A by 719,956 shares in the quarter, and has risen its stake in Healthcare Services Group Inc (NASDAQ:HCSG).

Proto Labs, Inc. (NYSE:PRLB)’s quarterly earnings will be published on February, 14., according to RTT. Analysts predict $0.69 EPS. That’s $0.16 up or 30.19 % from 2017’s earnings of $0.53. If reported the P/E will be 46.63 with $18.68M profit. -8.00 % negative EPS growth is what analysts predict. $0.75 EPS was published for previous quarter.

For more Proto Labs, Inc. (NYSE:PRLB) news brought out briefly go to: Seekingalpha.com, Benzinga.com, Seekingalpha.com, Seekingalpha.com or Fool.com. The titles are as follows: “Proto Labs: Still Thriving – Seeking Alpha” brought out on July 12, 2018, “60 Stocks Moving In Thursday’s Mid-Day Session – Benzinga” on October 25, 2018, “Proto Labs acquires Rapid Manufacturing for $120M – Seeking Alpha” with a publish date: November 21, 2017, “Proto Labs jumps +10% post Q3 earnings beats – Seeking Alpha” and the last “3 Stocks That Feel Like Netflix in 2002 – The Motley Fool” with publication date: April 25, 2018.

Proto Labs, Inc. (NYSE:PRLB) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.